SEC Tracker
Get the app

Adial Pharmaceuticals AZR

Adial Pharmaceuticals adjourns meeting

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. Meeting adjourned until Oct 26, 2026
  2. Nasdaq approval pending for proposals 3-6
  3. Proxies already submitted do not need action
  4. Definitive Proxy Statement filed Aug 24, 2026

Written from the DEFA14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Adial Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  2. Vyome Holdings HIND public float $6M, Jun 30, 2025
  3. Biomerica BMRA public float $7M, Nov 28, 2025
  4. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  5. PharmaCyte Biotech PMCB public float $6M, Oct 31, 2025